Analgesia, Epidural
Conditions
Brief summary
This study evaluates whether there is a correlation between intravascular injection rate and severity of cervical foraminal stenosis during cervical transforaminal epidural steroid injection
Detailed description
Cervical transforaminal epidural steroid injection (CTFESI) is useful option to improve cervical radicular pain. However, severe complication can occur by CTFESI such as epidural hematomas, infection, inadvertent intramedullary cord injections, and embolic infarct when inadvertent intra-arterial injection of particulate steroids has occurred. The incidence of intravascular injection during CTFESI was known as 20.6% \ 32.8% and it is higher than other level of spinal transforaminal epidural injection. To avoid complication due to intravascular injection during CTFESI, risk factors was should be evaluated. However, there was no study about risk factors of intravascular injection during CTFESI. The investigators could assume the severity of cervical neural foraminal spinal stenosis could affect the incidence of intravascular injection, pain intensity and effectiveness during CTFESI. Thus, the investigators designed this study to investigate whether there is a correlation between intravascular injection rate and severity of cervical foraminal stenosis during CTFESI.
Interventions
PROCEDURECervical transforaminal epidural steroid injection
Cervical transforaminal epidural steroid injection is a useful option in the diagnosis and treatment of cervical radicular pain.
Sponsors
Kyungpook National University Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients with radiating pain from cervical spinal stenosis and herniated nucleus pulposus.
Exclusion criteria
* Pregnancy, allergic to contrast media, patient refusal, and patients with persistent contraindication to nerve block such as coagulopathy and infection of the injection site.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intravascular injection | During procedure | Intravascular injection is defined as contrast media spreading out through the vascular channel during injection of contrast media under real time fluoroscopy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | Before treatment and at 1 month after treatment | Pain intensity will be evaluated using a numeric rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable). |
Countries
South Korea
Contacts
Primary ContactJimin Heo
Backup ContactSaeyoung Kim, PhD
Outcome results
None listed